Investors have a limited window left to buy Baudax Bio Inc. (BXRX) – Invest Chronicle

Investors have a limited window left to buy Baudax Bio Inc. (BXRX)

Baudax Bio Inc. (BXRX) is priced at $0.20 after the most recent trading session. At the very opening of the session, the stock price was $0.22 and reached a high price of $0.2205, prior to closing the session it reached the value of $0.21. The stock touched a low price of $0.2109.Recently in News on January 4, 2022, Baudax Bio to Present at the H.C. Wainwright BIOCONNECT Virtual Conference. Baudax Bio, Inc. (NASDAQ:BXRX) a pharmaceutical company focused on commercializing and developing innovative products for acute care settings, today announced that Gerri Henwood, the Company’s President and Chief Executive Officer, will present at the H.C. Wainwright BIOCONNECT Virtual Conference being held January 10 – 13, 2022. You can read further details here

Baudax Bio Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $0.2805 on 01/04/22, with the lowest value was $0.1915 for the same time period, recorded on 01/10/22.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free


Baudax Bio Inc. (BXRX) full year performance was -83.94%

Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Baudax Bio Inc. shares are logging -90.54% during the 52-week period from high price, and 4.75% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.19 and $2.12.

The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 800986 for the day, which was evidently lower, when compared to the average daily volumes of the shares.

When it comes to the year-to-date metrics, the Baudax Bio Inc. (BXRX) recorded performance in the market was -3.28%, having the revenues showcasing -63.70% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 17.95M, as it employees total of 57 workers.

Specialists analysis on Baudax Bio Inc. (BXRX)

During the last month, 0 analysts gave the Baudax Bio Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.

According to the data provided on, the moving average of the company in the 100-day period was set at 0.4773, with a change in the price was noted -0.32. In a similar fashion, Baudax Bio Inc. posted a movement of -61.93% for the period of last 100 days, recording 2,758,937 in trading volumes.

>> 7 Top Picks for the Post-Pandemic Economy << 

Trends and Technical analysis: Baudax Bio Inc. (BXRX)

Raw Stochastic average of Baudax Bio Inc. in the period of last 50 days is set at 2.15%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 4.30%. In the last 20 days, the company’s Stochastic %K was 9.74% and its Stochastic %D was recorded 9.61%.

Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -3.28%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -66.04%, alongside a downfall of -83.94% for the period of the last 12 months. The shares increased approximately by -2.93% in the 7-day charts and went up by -37.20% in the period of the last 30 days. Common stock shares were lifted by -63.70% during last recorded quarter.

Leave a Comment

Your email address will not be published. Required fields are marked *

On Key

Related Posts